Table 4.
Subgroup analysis for prevalence of hearing loss in pre-sarcopenia alone, obesity alone, and pre-sarcopenic obesity.
| Control 1 | Pre-Sarcopenia Alone | Obesity Alone | Pre-Sarcopenic Obesity | p Value | |
|---|---|---|---|---|---|
| Sex | |||||
| Women (n = 120,552) | 1.0 (Ref) | 1.23 (1.03–1.41) | 1.29 (1.14–1.45) | 1.44 (1.16–1.80) | <0.0001 |
| Men (n = 145,240) | 1.0 (Ref) | 1.21 (1.00–1.46) | 1.15 (1.06–1.25) | 1.15 (0.90–1.47) | |
| Age (years) | |||||
| <60 (n = 253,149) | 1.0 (Ref) | 1.17 (1.01–1.38) | 1.24 (1.14–1.35) | 1.43 (1.11–1.84) | <0.0001 |
| ≥60 (n = 12,643) | 1.0 (Ref) | 1.17 (0.98–1.40) | 1.12 (0.99–1.26) | 1.18 (0.95–1.46) |
1 Control = non-pre-sarcopenia and non-obesity. Multivariable-adjusted odds ratios (95% CI) were estimated after adjustments for age, sex, screening center, current smoker, heavy drinker, and regular physical activity, history of hypertension, HbA1c, and HDL-C. Abbreviations: CI, confidence interval; HbA1c, glycosylated hemoglobin; HDL-C, high-density lipoprotein.